Patent details

Basic Information

Publication number:

EP2976422

PCT Application Number:

GB2014050850

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147171714

PCT Publication Number:

WO2014147386

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CO-EXPRESSION OF FACTOR VIII AND VON WILLEBRAND FACTOR

French Title of Invention:

CO-EXPRESSION DU FACTEUR VIII ET DU FACTEUR DE VON WILLEBRAND

German Title of Invention:

GEMEINSAME EXPRESSION VON FAKTOR VIII UND DEM VON-WILLEBRAND-FAKTOR

SPC Number:

Dates

Filing date:

18/03/2014

Grant date:

13/12/2017

EP Publication Date:

27/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2017

EP B1 Publication Date:

13/12/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/03/2018

Expiration date:

18/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/12/2017

 

 

Name:

Profactor Pharma Ltd.

Address:

Roslin Biocentre, Roslin, Midlothian EH25 9PP, United Kingdom (GB)

Inventor

1

Name:

MCVEY, John Henderson

Address:

United Kingdom (GB)

2

Name:

DALE, Adele

Address:

United Kingdom (GB)

3

Name:

GARNER, Ian

Address:

United Kingdom (GB)

4

Name:

VERNON, Bruce

Address:

United Kingdom (GB)

Priority

Priority Number:

201304973

Priority Date:

19/03/2013

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

C12N 5/00;

Publication

European Patent Bulletin

Issue number:

201750

Publication date:

13/12/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1